Latest filing published 16 Sept 2026 for Adaptive Biotechnologies Corp, €3.3M.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Francis Lo: trading record in brief
All filings by Francis Lo on record concern Adaptive Biotechnologies Corp. We count 3 filings; the first trade dates from 4 June 2026 and the latest from 16 September 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 16 September 2026: a transaction of €3.3M, in Adaptive Biotechnologies Corp. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Francis Lo
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 142,198 shares@ US$26.68CommonSEC144:0001950047-26-009582
- 199,260 shares@ US$21.45100.0% of flowCommonSEC144:0001950047-26-006726
- 42,085 shares@ US$15.9913.4% of flowCommonSEC144:0001950047-26-005640
3 of 3 declarations
